Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDfs Furniture Plc Regulatory News (DFS)

Share Price Information for Dfs Furniture Plc (DFS)

Share Price is delayed by 15 minutes
Get Live Data
121.00    0.00 (0.00%)
Bid:
119.00
Ask:
121.00
Spread: 2.00 (1.681%)
Market Cap: £280.13m
DFS Live PriceLast checked at - London Stock Exchange

Intraday Dfs Furniture Plc Share Chart

Acquisition of Sofology

20 Nov 2017 07:33

RNS Number : 8986W
DFS Furniture plc
20 November 2017
 

20 November 2017

THIS STATEMENT CONTAINS INSIDE INFORMATION

DFS Furniture plc ("DFS" or the "Group")

Acquisition of Sofology

 

Further to our announcement on 3 August 2017 of the acquisition of Sofology Limited ("Sofology") (the "Acquisition"), DFS welcomes the announcement from the Competition & Markets Authority ("CMA") to allow the Group's acquisition of Sofology to proceed. There were no conditions attached to the CMA decision. The Financial Conduct Authority has also confirmed its clearance of the Acquisition.

The Acquisition will complete at the close of business on 30 November 2017.

 

DFS CEO, Ian Filby commented:

"I'm delighted that we are able to complete this deal, which is a big step for DFS towards achieving one of our strategic growth aims of broadening our product and brand appeal. Sofology is a fantastic business that takes great pride in the levels of service and innovation it provides to customers and is a great addition to our family.

This is an important and historic moment for both businesses, our investment demonstrates the confidence we have in Sofology and the wider Group. I look forward to working with Jason Tyldesley and his team to continue this success." 

 

DFS (enquiries via FTI)

FTI Consulting

Ian Filby (CEO)

Jonathon Brill

Nicola Bancroft (CFO)

Georgina Goodhew

Mike Schmidt (Director of Corporate Finance)

Eleanor Purdon

 

+44 (0) 20 3727 1000

 

dfsfurniture@fticonsulting.com

 

Our combined business in numbers (as at 20 November 2017):

DFS - 109 stores & 5 factories in the UK, 4 stores in Republic of Ireland, 6 stores in Netherlands and 2 stores in Spain

Sofology - 40 stores

Dwell - 33 stores (30 co-located with DFS stores)

Sofa Workshop - 24 stores (9 co-located with DFS stores)

Annual Revenues:(Latest publically published figures)

DFS, Dwell & Sofa Workshop combined revenues - £762.7m(Financial year ending 29 July 2017)

Sofology revenues - £143m(Financial year ending 31 December 2016)

 

Background - DFS

DFS is the market leading retailer of living room furniture in the United Kingdom. We design, manufacture, sell and deliver to our customers an extensive range of furniture products. The business operates a retail network of living room furniture stores in the United Kingdom and Europe, together with an online channel. These have been established and developed gradually over 48 years of operating history. We attract customers to our stores and website through our substantial and continued investment in nationwide marketing activities and our reputation for high quality products and service, breadth of product ranges and price points and favourable consumer financing options. 

 

Background - Sofology

Sofology is a UK based living room furniture retailer with a focus on upholstered furniture, now operating from 40 stores in the UK. The business was founded in 1974 by Brian & Margaret Tyldesley, who set-up Clayton Sales Rooms, which became CSL and finally Sofology in 2016. The business has developed a strong brand presence and prides itself on operating a relaxed and approachable style of service in store, which customers really appreciate. CEO Jason Tyldesley has led the business since 1996.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBRBPTMBBBBPR
Date   Source Headline
20th May 20264:31 pmRNSHolding(s) in Company
6th May 20267:00 amRNSDirectorate change
30th Apr 20267:00 amRNSPurchase of shares by Employee Benefit Trust
1st Apr 20263:06 pmRNSEBT Update
19th Mar 20267:00 amRNSInterim Results
20th Jan 20267:00 amRNSTrading Statement
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
31st Dec 20257:00 amRNSHolding(s) in Company
30th Dec 20257:00 amRNSTotal Voting Rights
8th Dec 20251:40 pmRNSTotal Voting Rights
17th Nov 20257:00 amRNSDirector/PDMR Shareholding
14th Nov 20254:17 pmRNSDirectorate change
14th Nov 20253:47 pmRNSResult of AGM
14th Nov 20257:00 amRNSAGM Trading Statement
13th Nov 20257:00 amRNSDirector/PDMR Shareholding
23rd Oct 20251:19 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSDirector/PDMR Shareholding
20th Oct 202510:35 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSDirector/PDMR Shareholding
14th Oct 20257:00 amRNSAnnual Financial Report
25th Sep 20257:00 amRNSFY25 Preliminary Results
12th Aug 20258:00 amRNSDirector Declaration
17th Jul 20257:00 amRNSTrading Statement
13th May 202511:59 amRNSHolding(s) in Company
10th Apr 202512:46 pmRNSInvestor Presentation via Investor Meet Company
9th Apr 202511:29 amRNSDirectorate Change
4th Apr 202510:37 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSInterim Results
24th Feb 20257:00 amRNSDirectorate Change
12th Feb 20251:15 pmRNSChange of Adviser
7th Feb 20253:14 pmRNSHolding(s) in Company
5th Feb 20259:28 amRNSHolding(s) in Company
29th Jan 20257:00 amRNSDirectorate Change
17th Jan 20257:00 amRNSTrading Statement
8th Jan 202512:05 pmRNSHolding(s) in Company
7th Jan 202512:34 pmRNSHolding(s) in Company
6th Jan 20252:47 pmRNSHolding(s) in Company
3rd Jan 20252:17 pmRNSHolding(s) in Company
13th Dec 20247:00 amRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSHolding(s) in Company
27th Nov 20247:00 amRNSValidation of SBTi Targets
25th Nov 202411:52 amRNSHolding(s) in Company
25th Nov 202410:57 amRNSHolding(s) in Company
22nd Nov 20243:31 pmRNSResult of AGM
22nd Nov 20247:00 amRNSTrading Update and Directorate Change
19th Nov 20249:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.